Enfortumab vedotin-ejfv (solution), CAS [[1346452-25-2]]

Product Overview

• Article Name: Enfortumab vedotin-ejfv (solution), CAS [[1346452-25-2]]
• Biozol Catalog Number: MCE-HY-P99016B
• Supplier Catalog Number: HY-P99016B
• Alternative Catalog Number: MCE-HY-P99016B-25MG,MCE-HY-P99016B-1MG,MCE-HY-P99016B-5MG,MCE-HY-P99016B-10MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien

Product Description

Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate (ADC). Enfortumab vedotin-ejfv (solution) is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE (HY-15162) via a protease-cleavable Val-Cit linker. The antibody portion is Enfortumab (HY-P99016), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Nectin-4 is an adhesion protein involved in cellular processes and tumorigenesis, and Enfortumab vedotin-ejfv (solution) is indicated for the inhibition of locally advanced or metastatic urothelial carcinoma[1][2].

Product Properties

• Molecular Weight: 152000 (average)
• Purity: 99.78
• CAS Number: [1346452-25-2]
• Target: Antibody-Drug Conjugates (ADCs),Nectin-4

Application Notes

• Application Notes: MCE Product type: ADC Related